Syncom Formulations (India) Limited - Asset Resilience Ratio

Latest as of September 2025: 31.53%

Syncom Formulations (India) Limited (SYNCOMF) has an Asset Resilience Ratio of 31.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Syncom Formulations (India) Limited's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs1.44 Billion

≈ $15.55 Million USD Cash + Short-term Investments

Total Assets

Rs4.56 Billion

≈ $49.32 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Syncom Formulations (India) Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Syncom Formulations (India) Limited (SYNCOMF) total assets.

Liquid Assets Composition Over Time

This chart breaks down Syncom Formulations (India) Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Syncom Formulations (India) Limited total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs1.44 Billion	31.53%
Total Liquid Assets	Rs1.44 Billion	31.53%

Asset Resilience Insights

Very High Liquidity: Syncom Formulations (India) Limited maintains exceptional liquid asset reserves at 31.53% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Syncom Formulations (India) Limited Industry Peers by Asset Resilience Ratio

Compare Syncom Formulations (India) Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Syncom Formulations (India) Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Syncom Formulations (India) Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	21.59%	Rs892.16 Million ≈ $9.65 Million	Rs4.13 Billion ≈ $44.69 Million	+4.74pp
2024-03-31	16.85%	Rs681.82 Million ≈ $7.37 Million	Rs4.05 Billion ≈ $43.76 Million	-1.68pp
2023-03-31	18.53%	Rs700.17 Million ≈ $7.57 Million	Rs3.78 Billion ≈ $40.86 Million	+5.54pp
2022-03-31	12.99%	Rs400.31 Million ≈ $4.33 Million	Rs3.08 Billion ≈ $33.33 Million	-11.47pp
2021-03-31	24.46%	Rs713.42 Million ≈ $7.72 Million	Rs2.92 Billion ≈ $31.54 Million	+24.26pp
2020-03-31	0.20%	Rs3.62 Million ≈ $39.15K	Rs1.81 Billion ≈ $19.52 Million	-0.09pp
2019-03-31	0.30%	Rs5.11 Million ≈ $55.25K	Rs1.73 Billion ≈ $18.71 Million	-2.72pp
2018-03-31	3.01%	Rs51.49 Million ≈ $556.83K	Rs1.71 Billion ≈ $18.49 Million	+2.63pp
2017-03-31	0.38%	Rs6.90 Million ≈ $74.62K	Rs1.80 Billion ≈ $19.48 Million	+0.31pp
2015-03-31	0.08%	Rs1.07 Million ≈ $11.55K	Rs1.38 Billion ≈ $14.88 Million	-1.23pp
2006-03-31	1.31%	Rs6.20 Million ≈ $67.04K	Rs473.07 Million ≈ $5.12 Million	--

pp = percentage points

About Syncom Formulations (India) Limited

NSE:SYNCOMF India Drug Manufacturers - Specialty & Generic

Market Cap

$188.37 Million

Rs17.42 Billion INR

Market Cap Rank

#16848 Global

#866 in India

Share Price

Rs18.53

Change (1 day)

-4.78%

52-Week Range

Rs10.30 - Rs21.39

All Time High

Rs26.77